Moderate riskFDA DrugClass II

Rising Pharma Temozolomide 5mg capsules recalled for failed stability testing

Rising Pharmaceuticals is recalling specific bottles of Temozolomide 5mg capsules because testing found the medication didn't meet quality standards for purity and stability. The issue was discovered during routine 9-month stability testing. This affects 1,200 bottles distributed nationwide with expiration date 09/2026.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have Temozolomide 5mg capsules from Rising Pharmaceuticals with lot #1TM0524003A and expiration date 09/2026.
  2. Do not use the medication if you have this lot number.
  3. Contact your pharmacy or doctor for a replacement or alternative medication.
  4. Return the recalled medication to your pharmacy.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
1200 bottles
Illnesses reported
None reported
Manufactured in
2 Tower Center Blvd Ste 1401, N/A, East Brunswick, NJ, United States
Classification
Class II
Recall number
D-0384-2026

In the FDA's words

Description
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51. Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing Lot #: 1TM0524003A, Exp. Date 09/2026. Distribution: Nationwide within the U.S Affected quantity: 1200 bottles
Hazard
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

Related topics

Unapproved drugsDrugsSold nationwideMore from FDA Drug